Chaturia Rouse1, Haley Gittleman1, Quinn T Ostrom1, Carol Kruchko1, Jill S Barnholtz-Sloan1. 1. Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio (C.R.); Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (H.G., Q.T.O., J.S.B.-S.); Central Brain Tumor Registry of the United States, Hinsdale, Illinois (H.G., Q.T.O., C. K., J.S.B.-S.).
Abstract
BACKGROUND: Years of potential life lost (YPLL) complement incidence and survival rates by measuring how much a patient's life is likely to be shortened by his or her cancer. In this study, we examine the impact of death due to brain and other central nervous system (CNS) tumors compared to other common cancers in adults by investigating the YPLL of adults in the United States. METHODS: Mortality and life table data were obtained from the Centers for Disease Control and Prevention's National Center for Health Statistics Vital Statistics Data for 2010. The study population included individuals aged 20 years or older at death who died from one of the selected cancers. YPLL was calculated by taking an individual's age at death and finding the corresponding expected remaining years of life using life table data. RESULTS: The cancers with the greatest mean YPLL were other malignant CNS tumors (20.65), malignant brain tumors (19.93), and pancreatic cancer (15.13) for males and malignant brain tumors (20.31), breast cancer (18.78), and other malignant CNS tumors (18.36) for females. For both sexes, non-Hispanic whites had the lowest YPLL, followed by non-Hispanic blacks, and Hispanics. CONCLUSION: Malignant brain and other CNS tumors have the greatest mean YPLL, thereby reflecting their short survival time post diagnosis. These findings will hopefully motivate more research into mitigating the impact of these debilitating tumors.
BACKGROUND: Years of potential life lost (YPLL) complement incidence and survival rates by measuring how much a patient's life is likely to be shortened by his or her cancer. In this study, we examine the impact of death due to brain and other central nervous system (CNS) tumors compared to other common cancers in adults by investigating the YPLL of adults in the United States. METHODS: Mortality and life table data were obtained from the Centers for Disease Control and Prevention's National Center for Health Statistics Vital Statistics Data for 2010. The study population included individuals aged 20 years or older at death who died from one of the selected cancers. YPLL was calculated by taking an individual's age at death and finding the corresponding expected remaining years of life using life table data. RESULTS: The cancers with the greatest mean YPLL were other malignant CNS tumors (20.65), malignant brain tumors (19.93), and pancreatic cancer (15.13) for males and malignant brain tumors (20.31), breast cancer (18.78), and other malignant CNS tumors (18.36) for females. For both sexes, non-Hispanic whites had the lowest YPLL, followed by non-Hispanic blacks, and Hispanics. CONCLUSION: Malignant brain and other CNS tumors have the greatest mean YPLL, thereby reflecting their short survival time post diagnosis. These findings will hopefully motivate more research into mitigating the impact of these debilitating tumors.
Authors: Haley R Gittleman; Quinn T Ostrom; Chaturia D Rouse; Jacqueline A Dowling; Peter M de Blank; Carol A Kruchko; J Bradley Elder; Steven S Rosenfeld; Warren R Selman; Andrew E Sloan; Jill S Barnholtz-Sloan Journal: Cancer Date: 2014-08-25 Impact factor: 6.860
Authors: Derek Reichel; Bien Sagong; James Teh; Yi Zhang; Shawn Wagner; Hongqiang Wang; Leland W K Chung; Pramod Butte; Keith L Black; John S Yu; J Manuel Perez Journal: ACS Nano Date: 2020-06-23 Impact factor: 15.881
Authors: Haley Gittleman; David J Cote; Quinn T Ostrom; Carol Kruchko; Timothy R Smith; Elizabeth B Claus; Jill S Barnholtz-Sloan Journal: J Neurooncol Date: 2017-06-30 Impact factor: 4.130
Authors: Kevin T Sheets; Matthew G Ewend; Mahsa Mohiti-Asli; Stephen A Tuin; Elizabeth G Loboa; Karen S Aboody; Shawn D Hingtgen Journal: Mol Ther Date: 2020-02-13 Impact factor: 11.454
Authors: Neal S Parikh; Jaclyn E Burch; Hooman Kamel; Lisa M DeAngelis; Babak B Navi Journal: J Stroke Cerebrovasc Dis Date: 2017-06-21 Impact factor: 2.136
Authors: David B Altshuler; Lin Wang; Lili Zhao; Zachary Miklja; Joey Linzey; Amanda Brezzell; Sofia Kakaizada; Saritha Krishna; Daniel A Orringer; Emily M Briceño; Nicolette Gabel; Shawn L Hervey-Jumper Journal: Neurooncol Pract Date: 2019-04-10